SIGMA-SYSTEMS
4.6.2019 10:02:18 CEST | Business Wire | Press release
Sigma Systems, the global leader in catalog-driven software, is pleased to announce that it has secured a deal to drive the next generation of digital services for one of the largest services providers in Brazil, in partnership with Engineering Do Brasil, a leading IT services provider and a subsidiary of Engineering Ingegneria Informatica S.p.A.
A new digital environment will be created to enable the rapid introduction and seamless selling of new digital offerings to customers across the country. Under the three-year agreement, Sigma Systems, in partnership with Engineering Do Brasil, will provide Sigma CPQ and Sigma Catalog to support the enablement of this new digital infrastructure, thus facilitating a greater level of agility and faster time-to-market for new products and offerings.
Tim Spencer, President and CEO, Sigma Systems, commented : “As a global software provider focused on enabling service providers to innovate quickly and launch new products and services, we are well-placed to support the needs of today’s digital consumer. In partnership with Engineering Do Brasil, we are confident that Sigma Catalog and Sigma CPQ will play a major role in unlocking new opportunities, as it delivers an array of new digital products and services for customers across the country.”
Sigma CPQ (Configure Price Quote), included in the latest edition of the Gartner Magic Quadrant for CPQ , is a telecom-specific, omni-channel quote and order-capture product that enables service providers to sell products, from standardized consumer offerings to complex tailored enterprise services. Deployed in the cloud or on-premise, Sigma CPQ increases the speed and improves the accuracy of sales quotes and orders with an immediate effect on sales efficiency, agility and customer satisfaction.
Deployed in the cloud or on-premise, Sigma Catalog accelerates product innovation to increase revenue from new digital products and new business models.
For further information about Sigma Systems, its award-winning Create-Sell-Deliver portfolio , and getting Next Done NowTM visit sigma-systems.com, or contact us on info@sigma-systems.com .
About Sigma Systems (Twitter @SigmaSystems)
Sigma Systems is the global leader in catalog-driven software solutions for communications, media, and high-tech companies. It serves over 80 customers in 40 countries with its award-winning products. The company’s portfolio spans enterprise-wide Catalog, Configure Price Quote (CPQ), Order Management, Provisioning, Insights and Portfolio Inventory products, and offers a core set of services including professional services, cloud services, and managed services. Sigma utilizes an agile approach to implementing its B/OSS products for its customers. Sigma has offices in North and South America, Europe and Asia Pacific, with technology and integration partners globally.
Additional information can be found online at https://sigma-systems.com/
About Engineering Do Brasil
Engineering Do Brasil is a Consulting and Information Technology global company specialized in Digital Transformation. Through Digital Transformation, Business Integration, Consulting and Outsourcing, Engineering Do Brasil transforms its customers’ operational processes compatible with those of the Digital Era. With more than 39 years of experience in the IT market, more than 10 thousand professionals and projects on more than 10 thousand large customers across various market segments, the experience of our group is being continuously improved by the investment in R&D, with more than 250 researchers, besides several partnerships with the main research centers and universities around the world. More information: https://www.eng.it/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190604005371/en/
Contact:
Adnan Bashir Senior Corporate Communications Manager Sigma Systems +1 647-204-0999
Chloe Purcell Head of PR Milner Strategic Marketing Ltd. +44 1473 633123
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom